These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28440912)

  • 1. Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.
    Carraro M; Minervini G; Giollo M; Bromberg Y; Capriotti E; Casadio R; Dunbrack R; Elefanti L; Fariselli P; Ferrari C; Gough J; Katsonis P; Leonardi E; Lichtarge O; Menin C; Martelli PL; Niroula A; Pal LR; Repo S; Scaini MC; Vihinen M; Wei Q; Xu Q; Yang Y; Yin Y; Zaucha J; Zhao H; Zhou Y; Brenner SE; Moult J; Tosatto SCE
    Hum Mutat; 2017 Sep; 38(9):1042-1050. PubMed ID: 28440912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are machine learning based methods suited to address complex biological problems? Lessons from CAGI-5 challenges.
    Savojardo C; Babbi G; Bovo S; Capriotti E; Martelli PL; Casadio R
    Hum Mutat; 2019 Sep; 40(9):1455-1462. PubMed ID: 31066146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of computational methods for the evaluation of pericentriolar material 1 missense variants in CAGI-5.
    Monzon AM; Carraro M; Chiricosta L; Reggiani F; Han J; Ozturk K; Wang Y; Miller M; Bromberg Y; Capriotti E; Savojardo C; Babbi G; Martelli PL; Casadio R; Katsonis P; Lichtarge O; Carter H; Kousi M; Katsanis N; Andreoletti G; Moult J; Brenner SE; Ferrari C; Leonardi E; Tosatto SCE
    Hum Mutat; 2019 Sep; 40(9):1474-1485. PubMed ID: 31260570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned.
    Niroula A; Vihinen M
    Hum Mutat; 2017 Sep; 38(9):1085-1091. PubMed ID: 28224672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blind prediction of deleterious amino acid variations with SNPs&GO.
    Capriotti E; Martelli PL; Fariselli P; Casadio R
    Hum Mutat; 2017 Sep; 38(9):1064-1071. PubMed ID: 28102005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases.
    Kasak L; Hunter JM; Udani R; Bakolitsa C; Hu Z; Adhikari AN; Babbi G; Casadio R; Gough J; Guerrero RF; Jiang Y; Joseph T; Katsonis P; Kotte S; Kundu K; Lichtarge O; Martelli PL; Mooney SD; Moult J; Pal LR; Poitras J; Radivojac P; Rao A; Sivadasan N; Sunderam U; Saipradeep VG; Yin Y; Zaucha J; Brenner SE; Meyn MS
    Hum Mutat; 2019 Sep; 40(9):1373-1391. PubMed ID: 31322791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessment.
    Scaini MC; Minervini G; Elefanti L; Ghiorzo P; Pastorino L; Tognazzo S; Agata S; Quaggio M; Zullato D; Bianchi-Scarrà G; Montagna M; D'Andrea E; Menin C; Tosatto SC
    Hum Mutat; 2014 Jul; 35(7):828-40. PubMed ID: 24659262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1- and BRCA2-specific in silico tools for variant interpretation in the CAGI 5 ENIGMA challenge.
    Padilla N; Moles-Fernández A; Riera C; Montalban G; Özkan S; Ootes L; Bonache S; Díez O; Gutiérrez-Enríquez S; de la Cruz X
    Hum Mutat; 2019 Sep; 40(9):1593-1611. PubMed ID: 31112341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAGI5: Objective performance assessments of predictions based on the Evolutionary Action equation.
    Katsonis P; Lichtarge O
    Hum Mutat; 2019 Sep; 40(9):1436-1454. PubMed ID: 31317604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense variant pathogenicity predictors generalize well across a range of function-specific prediction challenges.
    Pejaver V; Mooney SD; Radivojac P
    Hum Mutat; 2017 Sep; 38(9):1092-1108. PubMed ID: 28508593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What went wrong with variant effect predictor performance for the PCM1 challenge.
    Miller M; Wang Y; Bromberg Y
    Hum Mutat; 2019 Sep; 40(9):1486-1494. PubMed ID: 31268618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis.
    Aftab A; Shahzad S; Hussain HMJ; Khan R; Irum S; Tabassum S
    Breast Cancer; 2019 Jan; 26(1):11-28. PubMed ID: 30039340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis.
    Herzog CR; Noh S; Lantry LE; Guan KL; You M
    Mol Carcinog; 1999 Jun; 25(2):92-8. PubMed ID: 10365910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the performance of in silico methods for predicting the pathogenicity of variants in the gene CHEK2, among Hispanic females with breast cancer.
    Voskanian A; Katsonis P; Lichtarge O; Pejaver V; Radivojac P; Mooney SD; Capriotti E; Bromberg Y; Wang Y; Miller M; Martelli PL; Savojardo C; Babbi G; Casadio R; Cao Y; Sun Y; Shen Y; Garg A; Pal D; Yu Y; Huff CD; Tavtigian SV; Young E; Neuhausen SL; Ziv E; Pal LR; Andreoletti G; Brenner SE; Kann MG
    Hum Mutat; 2019 Sep; 40(9):1612-1622. PubMed ID: 31241222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reports from the fifth edition of CAGI: The Critical Assessment of Genome Interpretation.
    Andreoletti G; Pal LR; Moult J; Brenner SE
    Hum Mutat; 2019 Sep; 40(9):1197-1201. PubMed ID: 31334884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ensemble variant interpretation methods to predict enzyme activity and assign pathogenicity in the CAGI4 NAGLU (Human N-acetyl-glucosaminidase) and UBE2I (Human SUMO-ligase) challenges.
    Yin Y; Kundu K; Pal LR; Moult J
    Hum Mutat; 2017 Sep; 38(9):1109-1122. PubMed ID: 28544272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods.
    Critical Assessment of Genome Interpretation Consortium
    Genome Biol; 2024 Feb; 25(1):53. PubMed ID: 38389099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549.
    Zhang W; Zhu J; Bai J; Jiang H; Liu F; Liu A; Liu P; Ji G; Guan R; Sun D; Ji W; Yu Y; Jin Y; Meng X; Fu S
    J Exp Clin Cancer Res; 2010 Jun; 29(1):74. PubMed ID: 20565749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the CAGI-4 Hopkins clinical panel challenge.
    Chandonia JM; Adhikari A; Carraro M; Chhibber A; Cutting GR; Fu Y; Gasparini A; Jones DT; Kramer A; Kundu K; Lam HYK; Leonardi E; Moult J; Pal LR; Searls DB; Shah S; Sunyaev S; Tosatto SCE; Yin Y; Buckley BA
    Hum Mutat; 2017 Sep; 38(9):1155-1168. PubMed ID: 28397312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges.
    Daneshjou R; Wang Y; Bromberg Y; Bovo S; Martelli PL; Babbi G; Lena PD; Casadio R; Edwards M; Gifford D; Jones DT; Sundaram L; Bhat RR; Li X; Pal LR; Kundu K; Yin Y; Moult J; Jiang Y; Pejaver V; Pagel KA; Li B; Mooney SD; Radivojac P; Shah S; Carraro M; Gasparini A; Leonardi E; Giollo M; Ferrari C; Tosatto SCE; Bachar E; Azaria JR; Ofran Y; Unger R; Niroula A; Vihinen M; Chang B; Wang MH; Franke A; Petersen BS; Pirooznia M; Zandi P; McCombie R; Potash JB; Altman RB; Klein TE; Hoskins RA; Repo S; Brenner SE; Morgan AA
    Hum Mutat; 2017 Sep; 38(9):1182-1192. PubMed ID: 28634997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.